Oral contraceptives and neoplasms other than breast and female genital tract

European Journal of Cancer Prevention

Volumn 18, Issue 5, 2009, Pages 407-411

  Vecchia, Carlo La ^a   Bosetti, Cristina ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Colorectal cancer; Cutaneous malignant melanoma; Liver cancers; Lung cancer; Oral contraceptives; Risk; Thyroid cancer

Indexed keywords

ESTROGEN; GESTAGEN; ORAL CONTRACEPTIVE AGENT;

ARTICLE; BENIGN TUMOR; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; COLORECTAL TUMOR; EPIDEMIOLOGICAL DATA; HUMAN; LIVER CANCER; LIVER TUMOR; LUNG TUMOR; MELANOMA; PRIORITY JOURNAL; SKIN CARCINOMA; THYROID CANCER; TIME PERCEPTION;

BREAST NEOPLASMS; COLORECTAL NEOPLASMS; CONTRACEPTIVES, ORAL; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; NEOPLASMS;

EID: 69749115212     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32832caaca     Document Type: Article

References (49)

1. Beral V, Hermon C, Kay C, Hannaford P, Darby S, Reeves G (1999). Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study. BMJ 318:96-100. (Pubitemid 29188927)
2. Bosetti C, Bravi F, Negri E, La Vecchia C (2009). Oral contraceptives and colorectal cancer risk: a review meta-analysis. Hum Reprod Update. doi: 10.1093/humupd/dmp017
3. Bostick RM, Potter JD, Kushi LH, Sellers TA, Steinmetz KA, McKenzie DR, et al. (1994). Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control 5:38-52.
4. Campbell PT, Newcomb P, Gallinger S, Cotterchio M, McLaughlin JR (2007). Exogenous hormones and colorectal cancer risk in Canada: associations stratified by clinically defined familial risk of cancer. Cancer Causes Control 18:723-733. (Pubitemid 46988240)
5. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, et al. (2004). Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 350:991-1004. (Pubitemid 38269276)
6. Cote C (1997). Regression of focal nodular hyperplasia of the liver after oral contraceptive discontinuation. Clin Nucl Med 22:587-590. (Pubitemid 28049469)
7. Edmondson HA, Henderson B, Benton B (1976). Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med 294:470-472.
8. Fernandez E, La Vecchia C, D'Avanzo B, Franceschi S, Negri E, Parazzini F (1996). Oral contraceptives, hormone replacement therapy and the risk of colorectal cancer. Br J Cancer 73:1431-1435. (Pubitemid 26175681)
9. Fernandez E, La Vecchia C, Franceschi S, Braga C, Talamini R, Negri E, et al. (1998a). Oral contraceptive use and risk of colorectal cancer. Epidemiology 9:295-300. (Pubitemid 28194239)
10. Fernandez E, La Vecchia C, Braga C, Talamini R, Negri E, Parazzini F, et al. (1998b). Hormone replacement therapy and risk of colon and rectal cancer. Cancer Epidemiol Biomarkers Prev 7:329-333. (Pubitemid 28354145)
11. Fernandez E, La Vecchia C, Balducci A, Chatenoud L, Franceschi S, Negri E (2001). Oral contraceptives and colorectal cancer risk: a meta-analysis. Br J Cancer 84:722-727. (Pubitemid 32239011)
12. Furner SE, Davis FG, Nelson RL, Haenszel W (1989). A case-control study of large bowel cancer and hormone exposure in women. Cancer Res 49:4936-4940. (Pubitemid 19213651)
13. Giardiello FM, Hylind LM, Trimbath JD, Hamilton SR, Romans KE, Cruz-Correa M, et al. (2005). Oral contraceptives and polyp regression in familial adenomatous polyposis. Gastroenterology 128:1077-1080. (Pubitemid 40523557)
14. Hannaford P, Elliott A (2005). Use of exogenous hormones by women and colorectal cancer: evidence from the Royal College of General Practitioners' Oral Contraception Study. Contraception 71:95-98. (Pubitemid 40222060)
15. Hannaford PC, Kay CR, Vessey MP, Painter R, Mant J (1997). Combined oral contraceptives and liver disease. Contraception 55:145-151. (Pubitemid 27180389)
16. Hannaford PC, Selvaraj S, Elliott AM, Angus V, Iversen L, Lee AJ (2007). Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study. BMJ 335:651. (Pubitemid 46627503)
17. Heinemann LAJ, DoMinh T, Guggenmoos-Holzmann I, Thiel C, Garbe E (1997). Oral contraceptives and liver cancer: results of the multicentre international liver tumor study (MILTS). Contraception 56:275-284. (Pubitemid 28022879)
18. Heinemann LA, Weimann A, Gerken G, Thiel C, Schlaud M, DoMinh T (1998). Modern oral contraceptive use and benign liver tumors: the German Benign Liver Tumor Case-Control Study. Eur J Contracept Reprod Health Care 3:194-200. (Pubitemid 128690547)
19. IARC (1999). IARC Monographs on the evaluation of carcinogenic risks to humans. Hormonal contraception and post-menopausal hormonal therapy. Vol.72. Lyon: International Agency for Research on Cancer.
20. IARC (2007). IARC Monographs on the evaluation of carcinogenic risks to humans. Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy. Vol.91. Lyon: International Agency for Research on Cancer.
21. Kabat GC, Miller AB, Rohan TE (2008). Oral contraceptive use, hormone replacement therapy, reproductive history and risk of colorectal cancer in women. Int J Cancer 122:643-646.
22. Kampman E, Potter JD, Slattery ML, Caan BJ, Edwards S (1997). Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States. Cancer Causes Control 8:146-158. (Pubitemid 27170369)
23. Kinch R, Lough J (1978). Focal nodular hyperplasia of the liver and oral contraceptives. Am J Obstet Gynecol 132:717-727. (Pubitemid 9030460)
24. Klatskin G (1977). Hepatic tumors: possible relationship to use of oral contraceptives. Gastroenterology 73:386-394. (Pubitemid 8152460)
25. Kreuzer M, Gerken M, Heinrich J, Kreienbrock L, Wichmann HE (2003). Hormonal factors and risk of lung cancer among women? Int J Epidemiol 32:263-271.
26. Kune GA, Kune S, Watson LF (1990). Oral contraceptive use does not protect against large bowel cancer. Contraception 41:19-25. (Pubitemid 20018635)
27. La Vecchia C, Tavani A (2006). Female hormones and benign liver tumours. Dig Liver Dis 38:535-536. (Pubitemid 44356253)
28. La Vecchia C, Ron E, Franceschi S, Dal Maso L, Mark SD, Chatenoud L, et al. (1999). A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control 10:157-166.
29. La Vecchia C, Altieri A, Franceschi S, Tavani A (2001). Oral contraceptives and cancer: an update. Drug Saf 24:741-754.
30. Levi F, Pasche C, Lucchini F, La Vecchia C (2003). Oral contraceptives and colorectal cancer. Dig Liver Dis 35:85-87.
31. Lin J, Zhang SM, Cook NR, Manson JE, Buring JE, Lee IM (2007). Oral contraceptives, reproductive factors, and risk of colorectal cancer among women in a prospective cohort study. Am J Epidemiol 165:794-801. (Pubitemid 46434606)
32. Maheshwari S, Sarraj A, Kramer J, El-Serag HB (2007). Oral contraception and the risk of hepatocellular carcinoma. J Hepatol 47:506-513. (Pubitemid 47331743)
33. Martinez ME, Grodstein F, Giovannucci E, Colditz GA, Speizer FE, Hennekens C, et al. (1997). A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 6:1-5. (Pubitemid 27030419)
34. Mathieu D, Kobeiter H, Cherqui D, Rahmouni A, Dhumeaux D (1998). Oral contraceptive intake in women with focal nodular hyperplasia of the liver. Lancet 352:1679-1680. (Pubitemid 28526133)
35. Newcomb PA, Zheng Y, Chia VM, Morimoto LM, Doria-Rose VP, Templeton A, et al. (2007). Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women. Cancer Res 67:7534-7539. (Pubitemid 47206584)
36. Nichols HB, Trentham-Dietz A, Hampton JM, Newcomb PA (2005). Oral contraceptive use, reproductive factors, and colorectal cancer risk: findings from Wisconsin. Cancer Epidemiol Biomarkers Prev 14:1212-1218. (Pubitemid 40656469)
37. Peters RK, Pike MC, Chang WW, Mack TM (1990). Reproductive factors and colon cancers. Br J Cancer 61:741-748.
38. Potter JD, McMichael AJ (1983). Large bowel cancer in women in relation to reproductive and hormonal factors: a case-control study. J Natl Cancer Inst 71:703-709.
39. Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, et al. (1979). Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 242:644-648.
40. Rosenblatt KA, Gao DL, Ray RM, Nelson ZC, Thomas DB (2004). Contraceptive methods and induced abortions and their association with the risk of colon cancer in Shanghai, China. Eur J Cancer 40:590-593.
41. Scalori A, Tavani A, Gallus S, La Vecchia C, Colombo M (2002a). Oral contraceptives and the risk of focal nodular hyperplasia of the liver: a case-control study. Am J Obstet Gynecol 186:195-197. (Pubitemid 34165432)
42. Scalori A, Tavani A, Gallus S, La Vecchia C, Colombo M (2002b). Risk factors for focal nodular hyperplasia of the liver: an Italian case-control study. Am J Gastroenterol 97:2371-2373. (Pubitemid 35056051)
43. Scott LD, Katz AR, Duke JH, Cowan DF, Maklad NF (1984). Oral contraceptives, pregnancy, and focal nodular hyperplasia of the liver. JAMA 251:1461-1463. (Pubitemid 14161426)
44. Talamini R, Franceschi S, Dal Maso L, Negri E, Conti E, Filiberti R, et al. (1998). The influence of reproductive and hormonal factors on the risk of colon and rectal cancer in women. Eur J Cancer 34:1070-1076. (Pubitemid 28308348)
45. Troisi R, Schairer C, Chow WH, Schatzkin A, Brinton LA, Fraumeni JF Jr (1997). Reproductive factors, oral contraceptive use, and risk of colorectal cancer. Epidemiology 8:75-79. (Pubitemid 27014225)
46. Van Wayenburg CA, van der Schouw YT, van Noord PA, Peeters PH (2000). Age at menopause, body mass index, and the risk of colorectal cancer mortality in the Dutch Diagnostisch Onderzoek Mammacarcinoom (DOM) cohort. Epidemiology 11:304-308.
47. Vessey M, Painter R, Yeates D (2003). Mortality in relation to oral contraceptive use and cigarette smoking. Lancet 362:185-191. (Pubitemid 36859933)
48. Weiss NS, Daling JR, Chow WH (1981). Incidence of cancer of the large bowel in women in relation to reproductive and hormonal factors. J Natl Cancer Inst 67:57-60.
49. Wu-Williams AH, Lee M, Whittemore AS, Gallagher RP, Jiao DA, Zheng S, et al. (1991). Reproductive factors and colorectal cancer risk among Chinese females. Cancer Res 51:2307-2311.